Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients

BACKGROUND: Only a few patients who experience AML relapse derive lasting benefit from re-induction therapy. The utility of reassessing the disease karyotype at relapse is unclear. The main goals of this study were to identify prognostic factors for AML relapse and to determine the prognostic utilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yundeok, Jang, Jieun, Hyun, Shin Yong, Hwang, Dohyu, Kim, Soo Jeong, Kim, Jin Seok, Cheong, Jun-Won, Min, Yoo Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624999/
https://www.ncbi.nlm.nih.gov/pubmed/23589791
http://dx.doi.org/10.5045/br.2013.48.1.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624999/
https://www.ncbi.nlm.nih.gov/pubmed/23589791
http://dx.doi.org/10.5045/br.2013.48.1.24

Ejemplares similares